-
1
-
-
0037043655
-
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
-
Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347(6):408-15.
-
(2002)
N Engl J Med
, vol.347
, Issue.6
, pp. 408-415
-
-
Herbrecht, R.1
Denning, D.W.2
Patterson, T.F.3
Bennett, J.E.4
Greene, R.E.5
Oestmann, J.W.6
-
2
-
-
33846934215
-
Invasive aspergillosis following hematopoietic cell transplantation: Outcomes and prognostic factors associated with mortality
-
Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis. 2007;44(4):531-40.
-
(2007)
Clin Infect Dis
, vol.44
, Issue.4
, pp. 531-540
-
-
Upton, A.1
Kirby, K.A.2
Carpenter, P.3
Boeckh, M.4
Marr, K.A.5
-
3
-
-
58749083534
-
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry
-
Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis. 2009; 48(3):265-73.
-
(2009)
Clin Infect Dis
, vol.48
, Issue.3
, pp. 265-273
-
-
Neofytos, D.1
Horn, D.2
Anaissie, E.3
Steinbach, W.4
Olyaei, A.5
Fishman, J.6
-
4
-
-
53349171951
-
Factors associated with overall and attributable mortality in invasive aspergillosis
-
Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Ame S, Fohrer C, et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis. 2008;47(9): 1176-84.
-
(2008)
Clin Infect Dis
, vol.47
, Issue.9
, pp. 1176-1184
-
-
Nivoix, Y.1
Velten, M.2
Letscher-Bru, V.3
Moghaddam, A.4
Natarajan-Ame, S.5
Fohrer, C.6
-
5
-
-
34248160575
-
Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)
-
Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis. 2007;44(10):1289-97.
-
(2007)
Clin Infect Dis
, vol.44
, Issue.10
, pp. 1289-1297
-
-
Cornely, O.A.1
Maertens, J.2
Bresnik, M.3
Ebrahimi, R.4
Ullmann, A.J.5
Bouza, E.6
-
6
-
-
78249285274
-
The Nationwide Austrian Aspergillus Registry: A prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients
-
Perkhofer S, Lass-Florl C, Hell M, Russ G, Krause R, Honigl M, et al. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int J Antimicrob Agents. 2010;36(6):531-6.
-
(2010)
Int J Antimicrob Agents
, vol.36
, Issue.6
, pp. 531-536
-
-
Perkhofer, S.1
Lass-Florl, C.2
Hell, M.3
Russ, G.4
Krause, R.5
Honigl, M.6
-
7
-
-
77952975398
-
Factors associated with mortality in transplant patients with invasive aspergillosis
-
Baddley JW, Andes DR, Marr KA, Kontoyiannis DP, Alexander BD, Kauffman CA, et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis. 2010;50(12): 1559-67.
-
(2010)
Clin Infect Dis
, vol.50
, Issue.12
, pp. 1559-1567
-
-
Baddley, J.W.1
Andes, D.R.2
Marr, K.A.3
Kontoyiannis, D.P.4
Alexander, B.D.5
Kauffman, C.A.6
-
8
-
-
39449095735
-
Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America
-
Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008; 46(3):327-60.
-
(2008)
Clin Infect Dis
, vol.46
, Issue.3
, pp. 327-360
-
-
Walsh, T.J.1
Anaissie, E.J.2
Denning, D.W.3
Herbrecht, R.4
Kontoyiannis, D.P.5
Marr, K.A.6
-
9
-
-
58149088852
-
Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
-
Bohme A, Ruhnke M, Buchheidt D, Cornely OA, Einsele H, Enzensberger R, et al. Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2009;88(2):97-110.
-
(2009)
Ann Hematol
, vol.88
, Issue.2
, pp. 97-110
-
-
Bohme, A.1
Ruhnke, M.2
Buchheidt, D.3
Cornely, O.A.4
Einsele, H.5
Enzensberger, R.6
-
10
-
-
70349932352
-
Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: Results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
-
Girmenia C, Barosi G, Aversa F, Bacigalupo A, Barbui T, Baronciani D, et al. Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Clin Infect Dis. 2009;49(8):1226-36.
-
(2009)
Clin Infect Dis
, vol.49
, Issue.8
, pp. 1226-1236
-
-
Girmenia, C.1
Barosi, G.2
Aversa, F.3
Bacigalupo, A.4
Barbui, T.5
Baronciani, D.6
-
11
-
-
79955898005
-
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: Summary of the ECIL 3--2009 update
-
Maertens J, Marchetti O, Herbrecht R, Cornely OA, Fluckiger U, Frere P, et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update. Bone Marrow Transplant. 2011;46(5):709-18.
-
(2011)
Bone Marrow Transplant
, vol.46
, Issue.5
, pp. 709-718
-
-
Maertens, J.1
Marchetti, O.2
Herbrecht, R.3
Cornely, O.A.4
Fluckiger, U.5
Frere, P.6
-
12
-
-
46249126149
-
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
-
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813-21.
-
(2008)
Clin Infect Dis
, vol.46
, Issue.12
, pp. 1813-1821
-
-
De Pauw, B.1
Walsh, T.J.2
Donnelly, J.P.3
Stevens, D.A.4
Edwards, J.E.5
Calandra, T.6
-
13
-
-
49449103740
-
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria
-
Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis. 2008;47(5):674-83.
-
(2008)
Clin Infect Dis
, vol.47
, Issue.5
, pp. 674-683
-
-
Segal, B.H.1
Herbrecht, R.2
Stevens, D.A.3
Ostrosky-Zeichner, L.4
Sobel, J.5
Viscoli, C.6
-
14
-
-
70449647008
-
Proportional hazards tests and diagnostics based on weighted residuals
-
Grambsch P. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-55.
-
(1994)
Biometrika
, vol.81
, pp. 515-555
-
-
Grambsch, P.1
-
16
-
-
0000120995
-
A class of k-sample tests for comparing the cumulative incidence of a competing risk
-
Gray R. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Statist. 1988;16:1141-54.
-
(1988)
Ann Statist
, vol.16
, pp. 1141-1154
-
-
Gray, R.1
-
17
-
-
77955553749
-
The mstate package for estimation and prediction in non-and semi-parametric multistate and competing risks models
-
de Wreede LC, Fiocco M, Putter H. The mstate package for estimation and prediction in non-and semi-parametric multistate and competing risks models. Comput Methods Programs Biomed. 2010;99(3): 261-74.
-
(2010)
Comput Methods Programs Biomed
, vol.99
, Issue.3
, pp. 261-274
-
-
de Wreede, L.C.1
Fiocco, M.2
Putter, H.3
-
18
-
-
81255171499
-
Epidemiological trends in invasive aspergillosis in France: The SAIF network (2005-2007)
-
Lortholary O, Gangneux JP, Sitbon K, Lebeau B, de Monbrison F, Le Strat Y, et al. Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007). Clin Microbiol Infect. 2011; 17(12):1882-9
-
(2011)
Clin Microbiol Infect
, vol.17
, Issue.12
, pp. 1882-1889
-
-
Lortholary, O.1
Gangneux, J.P.2
Sitbon, K.3
Lebeau, B.4
de Monbrison, F.5
Le Strat, Y.6
-
19
-
-
0032971423
-
Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation
-
Ribaud P, Chastang C, Latge JP, Baffroy-Lafitte L, Parquet N, Devergie A, et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis. 1999;28 (2):322-30.
-
(1999)
Clin Infect Dis
, vol.28
, Issue.2
, pp. 322-330
-
-
Ribaud, P.1
Chastang, C.2
Latge, J.P.3
Baffroy-Lafitte, L.4
Parquet, N.5
Devergie, A.6
-
20
-
-
33645052698
-
Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: A 1-year retrospective study of consecutive patients at French transplantation centers
-
Cordonnier C, Ribaud P, Herbrecht R, Milpied N, Valteau-Couanet D, Morgan C, et al. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers. Clin Infect Dis. 2006;42(7):955-63.
-
(2006)
Clin Infect Dis
, vol.42
, Issue.7
, pp. 955-963
-
-
Cordonnier, C.1
Ribaud, P.2
Herbrecht, R.3
Milpied, N.4
Valteau-Couanet, D.5
Morgan, C.6
-
21
-
-
0037114705
-
Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors
-
Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002;100(13):4358-66.
-
(2002)
Blood
, vol.100
, Issue.13
, pp. 4358-4366
-
-
Marr, K.A.1
Carter, R.A.2
Boeckh, M.3
Martin, P.4
Corey, L.5
-
22
-
-
0031010201
-
Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation
-
Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis. 1997;175(6):1459-66.
-
(1997)
J Infect Dis
, vol.175
, Issue.6
, pp. 1459-1466
-
-
Wald, A.1
Leisenring, W.2
van Burik, J.A.3
Bowden, R.A.4
-
23
-
-
77950280868
-
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database
-
Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50(8):1091-100.
-
(2010)
Clin Infect Dis
, vol.50
, Issue.8
, pp. 1091-1100
-
-
Kontoyiannis, D.P.1
Marr, K.A.2
Park, B.J.3
Alexander, B.D.4
Anaissie, E.J.5
Walsh, T.J.6
-
24
-
-
15744365906
-
Combination antifungal therapy for invasive aspergillosis
-
Cesaro S, Visintin G. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis. 2005;40(7):1073-5.
-
(2005)
Clin Infect Dis
, vol.40
, Issue.7
, pp. 1073-1075
-
-
Cesaro, S.1
Visintin, G.2
|